Patient P-02478
Synthetic patientMETA-24 · Day 164 · 35–44 · M · baseline S19Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Stable
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S19
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity-8
- GI instability-7
- Treatment adherence+5
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable93 min
stable · +3.1 vs previous 14 d
Sleep duration
Wearable6.1 h
stable · -0.1 vs previous 14 d
Energy level
Daily log5.7/10
stable · +0.0 vs previous 14 d
Steps
Wearable9,328
stable · -56 vs previous 14 d
GI burden
Companion24/100
worsening · +5.6 vs previous 14 d
Adherence
Companion97.6 %
stable · +1.5 vs previous 14 d
Sleep quality
Wearable44.4/100
worsening · -2.3 vs previous 14 d
Glucose, CGM daily mean
CGM136 mg/dL
stable · +5.0 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 81 from the failing basin, 9 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +6.6
- Proteinsupporter · GI -3.8 next day
Main detractors to watch
- Bacteroides fragilis elevatedhidden · steering -7.4
- Low-HRV stretchperturbation · steering -2.7
- Dietary driftperturbation · steering -2.6
- Alcohol on dosing daysperturbation · steering -1.8
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.8supporter · 95%
- Dietary fat load+2.3no signal · 50%
- Histamine load+1.4no signal · 22%
- Alcohol-0.7no signal · 15%
- Caffeine-0.6no signal · 15%
- Simple carbohydrates-0.5no signal · 15%
- Ultra-processed food+0.4no signal · 15%
- Insoluble fibre+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↑20
- WearableShort sleep window
- Mucosal barrier integrity ↓10
- WearableSleep 6.1 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 4.6 · butyrate capacity 49/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 55 ms
- Sleep
- 6.8 h
- Steps
- 10,043
- Resting HR
- 65 bpm
Daily log: GI score 24, nutritional resilience 60, adherence 98.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.